---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-105953"
form_type: "8-K"
ticker: "UTHR"
cik: "0001082554"
company_name: "UNITED THERAPEUTICS Corp"
filed_at: "2026-09-08T21:12:57+00:00"
generated_at: "2026-09-08T21:14:19.706704+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# United Therapeutics enters $477.6M ASR to complete $2B buyback authorization

## Summary
- Entered ASR with Citibank to repurchase ~$477.6M stock; upfront payment ~Sept 10, 2026.
- Initial delivery ~719,376 shares (75% of anticipated total based on 9/8/26 close); final settlement Q4 2026.
- Prior repurchases: $1.5B ASR in March 2026 and $22.4M open-market in Q3 2026.
- CEO states $4B returned to shareholders in ~2.5 years; ~42.9M shares outstanding as of Sept 4, 2026.

## SEC filing metadata
- accession: 0001104659-26-105953
- form_type: 8-K
- ticker: UTHR
- cik: 0001082554
- company_name: UNITED THERAPEUTICS Corp
- filed_at: 2026-09-08T21:12:57+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1082554/000110465926105953/0001104659-26-105953-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1082554/000110465926105953/tm2624887d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-105953
- JSON: https://secwatch.observer/filing/0001104659-26-105953.json
- Plain text: https://secwatch.observer/filing/0001104659-26-105953.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.